Yu Xia
Direktor/Vorstandsmitglied bei AKESO, INC.
Vermögen: 28 Mio $ am 31.05.2024
Profil
Dr. Yu Xia is on the Board of Directors at Akeso, Inc. Dr. Xia was previously employed as a Director-Global Quality by Albany Molecular Research, Inc., an Associate Director by Apotex, Inc., and a Manager by Correvio Pharma Corp.
He received his undergraduate degree from Peking University and a doctorate degree from the University of Wales (Bangor).
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
AKESO, INC.
0,58% | 28.03.2024 | 5 019 296 ( 0,58% ) | 28 Mio $ | 31.05.2024 |
Aktive Positionen von Yu Xia
| Unternehmen | Position | Beginn |
|---|---|---|
| AKESO, INC. | Direktor/Vorstandsmitglied | 01.11.2019 |
Ehemalige bekannte Positionen von Yu Xia
| Unternehmen | Position | Ende |
|---|---|---|
| ALBANY MOLECULAR RESEARCH, INC. | Corporate Officer/Principal | 01.08.2016 |
Apotex, Inc.
 Apotex, Inc. Pharmaceuticals: MajorHealth Technology Apotex, Inc. operates as a generic pharmaceutical company that offers medicines. It engages in research and development, bioequivalence, and clinical studies. The company was founded by Dr. Bernard Sherman in 1974 and is headquartered in Toronto, Canada. | Corporate Officer/Principal | 01.12.2013 |
| CORREVIO PHARMA CORP. | Corporate Officer/Principal | - |
Ausbildung von Yu Xia
| Peking University | Undergraduate Degree |
| University of Wales (Bangor) | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AKESO, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Correvio Pharma Corp.
 Correvio Pharma Corp. Pharmaceuticals: MajorHealth Technology Correvio Pharma Corp. operates as a pharmaceutical company, which engages in the provision of development and commercialization of medical products. It operates through the Europe and Rest of the World geographical segments. The firm focuses on cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease. It offers the Brinavess and Aggrastat products to customers such as physicians, patients and healthcare systems. The company was founded in 1986 and is headquartered in Vancouver, Canada. | Health Technology |
Apotex, Inc.
Apotex, Inc. Pharmaceuticals: MajorHealth Technology Apotex, Inc. operates as a generic pharmaceutical company that offers medicines. It engages in research and development, bioequivalence, and clinical studies. The company was founded by Dr. Bernard Sherman in 1974 and is headquartered in Toronto, Canada. | Health Technology |
Curia Global, Inc.
 Curia Global, Inc. BiotechnologyHealth Technology Curia Global, Inc. engages in drug research and development, and manufacturing. It offers drug delivery, drug development, analytical services, API development and manufacturing, and drug product solutions. The company was founded by Thomas E. D'Ambra on June 19, 1991 and is headquartered in Albany, NY. | Health Technology |
